Candriam S.C.A. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,660,323
-39.4%
151,901
-20.8%
0.03%
-41.1%
Q2 2023$7,689,473
+13.8%
191,901
+6.7%
0.06%
+19.1%
Q1 2023$6,757,568
-38.9%
179,901
-20.7%
0.05%
-37.3%
Q4 2022$11,055,766
+15.5%
226,911
+26.1%
0.08%
+11.9%
Q3 2022$9,569,000
+26.4%
179,901
+38.5%
0.07%
+8.1%
Q2 2022$7,573,000
-43.0%
129,901
-25.4%
0.06%
-31.1%
Q1 2022$13,285,000
-4.0%
174,081
-24.3%
0.09%
+2.3%
Q4 2021$13,844,000
+20.6%
230,081
+12.3%
0.09%
+12.8%
Q3 2021$11,477,000
+706.0%
204,960
+361.2%
0.08%
+239.1%
Q2 2018$1,424,000
+2.9%
44,4400.0%0.02%
-4.2%
Q1 2018$1,384,000
-35.5%
44,440
-5.4%
0.02%
-35.1%
Q4 2017$2,146,000
+7.8%
47,000
-11.3%
0.04%
+5.7%
Q3 2017$1,990,000
-21.3%
53,0000.0%0.04%
-27.1%
Q2 2017$2,528,000
-7.6%
53,000
-11.7%
0.05%
-9.4%
Q1 2017$2,736,000
-14.3%
60,000
+66.7%
0.05%
-20.9%
Q4 2014$3,192,00036,0000.07%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,799,916$121,768,0008.62%
Tamarack Advisers, LP 625,000$27,044,0008.22%
NEXTHERA CAPITAL LP 149,086$6,484,0005.40%
Spyglass Capital Management LLC 379,609$16,509,0005.22%
Gagnon Advisors, LLC 107,412$4,671,0002.67%
GAGNON SECURITIES LLC 278,613$12,117,0002.61%
Asymmetry Capital Management, L.P. 84,735$3,685,0002.00%
Rock Springs Capital Management LP 1,250,000$54,363,0001.97%
Lisanti Capital Growth, LLC 118,620$5,159,0001.68%
Elk Creek Partners, LLC 500,069$21,748,0001.62%
View complete list of PACIRA PHARMACEUTICALS INC shareholders